Cargando…
Cancer neoantigens and immunogenicity: mutation position matters
Cancer mutations can elicit protective immunity. Computational methods are critical for selecting these neoantigens for immunotherapy. While significant progress has been made in the field in predicting peptide presentation, our understanding of which mutated peptide is recognized as foreign by T ce...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199756/ https://www.ncbi.nlm.nih.gov/pubmed/32391432 http://dx.doi.org/10.1080/23723556.2020.1740071 |